| Trial ID: | L2446 |
| Source ID: | NCT00700648
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised Subjects
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin aspart
|
| Outcome Measures: |
Primary: Incidence of AEs (adverse event), After 6 months|Incidence of SAEs (serious adverse event), After 6 months | Secondary: Other safety & efficacy measures, After 6 months
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
3024
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-03
|
| Completion Date: |
2008-09
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-04
|
| Locations: |
Novo Nordisk Investigational Site, Bangalore, 560001, India
|
| URL: |
https://clinicaltrials.gov/show/NCT00700648
|
